India · English
Margin caps on cancer drugs, could there be more on the anvil? Explained
The Centre has cracked down on steep cancer drug prices, under the watch of the Supreme Court, and the coming weeks will unravel granular details on these measures aimed at putting a lid on “profiteering” and ensuring fairer prices to patients.
Read the full report at The Hindu BusinessLine →
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.